Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | TUBB4A | P04350 | 4/20 | 0.50 |
| ▸ | TUBB | P07437 | 4/20 | 0.50 |
| ▸ | TUBA3C | P0DPH7 | 4/20 | 0.50 |
| ▸ | TUBA1B | P68363 | 4/20 | 0.50 |
| ▸ | TUBA4A | P68366 | 4/20 | 0.50 |
| ▸ | TUBB4B | P68371 | 4/20 | 0.50 |
| ▸ | TUBB3 | Q13509 | 4/20 | 0.50 |
| ▸ | TUBB2A | Q13885 | 4/20 | 0.50 |
| ▸ | TUBB8 | Q3ZCM7 | 4/20 | 0.50 |
| ▸ | TUBA3E | Q6PEY2 | 4/20 | 0.50 |
| ▸ | TUBA1A | Q71U36 | 4/20 | 0.50 |
| ▸ | TUBA1C | Q9BQE3 | 4/20 | 0.50 |
| ▸ | TUBB6 | Q9BUF5 | 4/20 | 0.50 |
| ▸ | TUBB2B | Q9BVA1 | 4/20 | 0.50 |
| ▸ | TUBB1 | Q9H4B7 | 4/20 | 0.50 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.49 |
| ▸ | KRAS | P01116 | 2/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | CTSV | O60911 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4640437 | 0.84 | MAPT (0.54) | PKMPTGS2HTTMAPTALDH1A1 | |
| SCHEMBL6716574 | 0.83 | ANO1 (0.50) | PKMHTTCTSVCTSLMAPT | |
| SCHEMBL6716569 | 0.83 | ANO1 (0.50) | PKMHTTCTSVCTSLMAPT | |
| SCHEMBL27495943 | 0.82 | LMNA (0.48) | PKMCTSVCTSLMAPTALDH1A1 | |
| SCHEMBL6792388 | 0.81 | ALDH1A1 (0.52) | TUBB4ATUBBTUBA3CTUBA1BTUBA4A | |
| SCHEMBL1671926 | 0.80 | CTSV (0.60) | PKMHTTCTSVCTSLMAPT | |
| SCHEMBL4602879 | 0.80 | KDM4E (0.59) | MAPTALDH1A1 | |
| SCHEMBL9192295 | 0.79 | CTSV (0.59) | PKMHTTCTSVCTSLMAPT | |
| SCHEMBL10757843 | 0.79 | PKM (0.63) | PKMPTGS2KRASHTTCTSV | |
| SCHEMBL15486506 | 0.79 | CTSV (0.59) | PKMHTTCTSVCTSLMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0934924-B1 | NOVEL DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME | KOWA CO (JP) | 2008-08-13 | — | — | EP | disclosed |
| EP-1057815-B1 | CYCLIC AMIDE COMPOUNDS | KOWA CO (JP) | 2007-09-05 | — | — | EP | disclosed |
| US-6828316-B2 | Antiallergens | KOWA CO., LTD. (JP) | 2004-12-07 | — | — | US | disclosed |
| US-6645957-B2 | Useful in preventing and treating allergic immunological diseases; treating asthma, atopic dermatitis, allergic rhinitis, inflammatory large bowel disease, contact dermatitis | KOWA CO., LTD. (JP) | 2003-11-11 | — | — | US | disclosed |
| US-6576642-B2 | Inhibitors of the production of Ig E antibodies, antiallergens | KOWA CO., LTD. (JP) | 2003-06-10 | — | — | US | disclosed |
| US-20030096828-A1 | Cyclic amide compound | KOWA CO., LTD. (JP) | 2003-05-22 | — | — | US | disclosed |
| US-6448242-B1 | COMPOUND HAVING A STRONG INHIBITORY EFFECT ON THE PRODUCTION OF AN IGE ANTIBODY; ANTIALLERGENS | KOWA CO., LTD. (JP) | 2002-09-10 | — | — | US | disclosed |
| US-20020042414-A1 | Diamide compound and medicine containing the same | KOWA CO., LTD. (JP) | 2002-04-11 | — | — | US | disclosed |
| US-6340682-B1 | FOR THERAPY OF ALLERGIC IMMUNOLOGICAL DISEASE IS SELECTED FROM ASTHMA, ALLERGIC RHINITIS, INFLAMMATORY LARGE BOWEL DISEASE OR CONTACT DERMATITIS | KOWA CO., LTD. (JP) | 2002-01-22 | — | — | US | disclosed |
| US-20010039279-A1 | Diamide compounds and compositions containing the same | KOWA CO., LTD. (JP) | 2001-11-08 | — | — | US | disclosed |
| US-6297283-B1 | EXCELLENT INHIBITORY EFFECT ON THE PRODUCTION OF AN IGE ANTIBODY AND ARE HENCE USEFUL AS ANTIALLERGIC AGENTS | KOWA CO., LTD. (JP) | 2001-10-02 | — | — | US | disclosed |
| EP-1057815-A1 | CYCLIC AMIDE COMPOUNDS | Kowa Co., Ltd. (JP) | 2000-12-06 | — | — | EP | disclosed |
| EP-0934924-A1 | NOVEL DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME | KOWA CO. LTD. (JP) | 1999-08-11 | — | — | EP | disclosed |
| EP-0926138-A1 | DIAMIDE COMPOUNDS AND DRUGS CONTAINING THE SAME | KOWA CO. LTD. (JP) | 1999-06-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010039279-A1 | Diamide compounds and compositions containing the same | HRH4, HRH2, HRH1 | PKM 4650/4885TUBB4A 522/4885TUBB 732/4885 |
| US-20030096828-A1 | Cyclic amide compound | CMA1, HRH2, HRH4 | PKM 4761/4885TUBB4A 2523/4885TUBB 2712/4885 |
| US-20020042414-A1 | Diamide compound and medicine containing the same | HRH4, HRH2, HRH1 | PKM 3494/4885TUBB4A 1824/4885TUBB 2033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.